. Counting costs. Patients will suffer from limits on Alzheimer's drugs. Nurs Stand. 2005 May 25-31;19(37):24-5. PubMed.

Recommends

Please login to recommend the paper.

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

  1. This is sobering news from a national health service that makes tough choices on balancing costs for AD medications with data on their long-term as well as short-term efficacy.